Hindlll polymorphism of lipoprotein lipase gene in patients with acute coronary syndrome
Abstract
Aim. To study the role of lipoprotein lipase (LPL) gene HindIII polymorphism in hospital and post-hospital prognosis of acute coronary syndrome (ACS).
Material and methods. The study included 423 ACS patients. In 382 participants with verified myocardial infarction (MI) and unstable angina (UA), LPL gene HindIII polymorphism was analyzed. Hospital and post-hospital (one-year) ACS outcomes were registered.
Results. The prevalence of LPL gene Н+/+, Н+/- and Н-/- genotypes was similar among patients with MI and ST segment elevation (ST-MI) and participants with MI, UAand no ST segment elevation (non-ST-MI). At the same time, among those under 65 years, genotype patterns were different in ST-MI vs. UA patients (df=2, p=0,017), mostly due to high prevalence of Н+/+genotype (77 % and 42 %, respectively). Genotype distribution in non-ST-MI patients could be described as intermediate. Hospital and post-hospital lethality, as well as non-fatal ACS complication rate, was similar in different genotype groups. Lethality risk, calculated by hospital risk scale, was higher in elderly Н+/+ carriers. Age-related increase in post-hospital lethality was typical only for Н+/+ carriers (for every 5 years, adjusted risk of cardiovascular death increased by 2,89 (1,23; 6,76) times). No similar tendency was observed for Н- carriers.
Conclusion. LPL gene Н+/+ genotype was associated with ST-MI, but only in those under 65 years. Elderly carriers of this genotype had relatively high risk of hospital and post-hospital death
About the Authors
R. T. SaygitovRussian Federation
M. G. Glezer
Russian Federation
N. A. Malygina
Russian Federation
References
1. Heinzmann C, Ladias J, Antonarakis S, et al. RFLP for the human lipoprotein lipase (LPL) gene: HindIII. Nucleic Acids Res 1987; 15: 6763.
2. Schneider J, Kreuzer J, Hamann A, et al. The proline 12 alanine substitution in the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo. Diabetes 2002; 51(3): 867-70.
3. Hallman DM, Groenemeijer BE, Jukema JW, et al. Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci. Ann Hum Genet 1999; 63(6): 499-510.
4. Chamberlain JC, Thorn JA, Oka K, et al. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 1989; 79: 85-91.
5. Ahn YI, Kamboh MI, Hamman RF, et al. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 1993; 34: 421-8.
6. Peacock RE, Hamsten A, Nilsson-Ehle P, et al. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992; 97: 171-85.
7. Mattu RK, Needham EW, Morgan R, et al. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 1994; 14(7): 1090-7.
8. Gambino R, Scaglione L, Alemanno N, et al. Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction. Metabolism 1999; 48(9): 1157-61.
9. Jemaa R, Fumeron F, Poirier O, et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 1995; 36(10): 2141-6.
10. Gerdes C, Gerdes LU, Hansen PS, et al. Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation 1995; 92(7): 1765-9.
11. Humphries SE, Nicaud V, Margalef J, et al. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 1998; 18: 526-34.
12. Hokanson JE. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int J Clin Lab Res 1997; 27(1): 24-34.
13. Holmer SR, Hengstenberg C, Mayer B, et al. Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population. Cardiovasc Res 2000; 47(4): 806-12.
14. Hengstenberg C, Brockel U, Holmer S, et al. Genetic factors in myocardial infarction-Results from a candidate gene and a genome-wide approach between beta blockers. Herz 2002; 27(7): 649-61.
15. Larson I, Hoffmann MM, Ordovas JM, et al. The lipoprotein lipase HindIII polymorphism: association with total cholesterol and LDL-cholesterol, but not with HDL and triglycerides in 342 females. Clin Chem 1999; 45(7): 963-8.
16. Senti M, Bosch M, Aubo C, et al. Relationship of abdominal adiposity and dyslipemic status in women with a common mutation in the lipoprotein lipase gene. Atherosclerosis 2000; 150(1): 135-41.
17. Senti M, Elosua R, Tomas M, et al. Physical activity modulates the combined effect of a common variant of the lipoprotein lipase gene and smoking on serum triglyceride levels and highdensity lipoprotein cholesterol in men. Hum Genet 2001; 109(4): 385-92.
18. Corella D, Guillen M, Saiz C, et al. Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus. J Lipid Res 2002; 43(3): 416-27.
19. Hall S, Talmud PJ, Cook DG, et al. Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: the Wandsworth Heart and Stroke Study. Genet Epidemiol 2000; 18(3): 203-16.
20. Сайгитов Р.Т., Глезер М.Г., СеменцовД.П. и др. Особенности прогнозирования при остром коронарном синдроме у мужчин и женщин. Кардиоваск тер профил 2006; 5(1): 63-70.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
22. Сайгитов Р.Т., Глезер М.Г., Семенцов Д.П. и др. Прогнозирование госпитальных исходов при остром коронарном синдроме. РКЖ 2006; 2: 42-50.
23. Сайгитов Р.Т., Глезер М.Г., Семенцов Д.П. и др. ID полиморфизм гена ангиотензинпревращающего фермента у больных с острым коронарным синдромом. Кардиоваск тер профил 2006; 5(8): 34-41.
24. Burzotta F, Paciaroni K, De Stefano V, et al. G20210A Prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12 034 subjects. Heart 2004; 90: 82-6.
25. Fan YM, Lehtimaki T, Rontu R, et al. Age-dependent association between hepatic lipase gene C-480T polymorphism and the risk of pre-hospital sudden cardiac death: The Helsinki Sudden Death Study. Atherosclerosis 2007; 192(2): 421-7.
26. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-6.
27. Sesso HD, Lee I-M, Gaziano JM, et al. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation 2001; 104: 393-8.
28. Chiappelli M, Tampieri C, Tumini E, et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 2005; 32(6): 349-53. Thorn JA, Chamberlain JC, Alcolado JC, et al. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 1990; 85: 55-60.
29. Thorn JA, Chaтberlain JC, Alcolado JC, et аl. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 1990; 85: 55-60.
Review
For citations:
Saygitov R.T., Glezer M.G., Malygina N.A. Hindlll polymorphism of lipoprotein lipase gene in patients with acute coronary syndrome. Cardiovascular Therapy and Prevention. 2008;7(8):39-44. (In Russ.)